Unleashing Innovation Xentria Meitheal, the Collaboration Engine

Xentria and Meitheal ink licensing deal for rare lung disease treatment in North America. Xentria will license its experimental pulmonary sarcoidosis drug to ... Meitheal Pharmaceuticals, Chicago, IL, Generics. Add'l Locations Novian Health ... Xentria, Chicago, IL, Biologics & Biosimilars, Monoclonal Antibody. Add'l ... ... Meitheal's General Counsel & Corporate Secretary since its inception in 2017. In addition, Victoria is the Corporate Secretary of Xentria, Inc. a biotech ... Xentria is a biologics development company working closely with Meitheal Pharmaceuticals (Chicago, IL),. NKF Pharma (Nanking, China), and KinBio (Rehovot, ... Meitheal Pharmaceuticals Grows Specialty Biopharmaceuticals Portfolio with Exclusive Commercial Licensing Agreement for XENLETA® (lefamulin ... 2023 - 2024 Associate Director, Human Resources @ Xentria, Inc. 2020 - 2022 Corporate Recruiter - Human Resources Manager @ Meitheal Pharmaceuticals, Inc. see ... Meitheal Pharmaceuticals, Inc., a fully ... Meitheal. Dr. Jiali Luo brings extensive ... 224-443-4615 [email protected]. Legal. Xentria Secures Landmark Agreement with NYU for Cardiovascular Therapy Development. 12/19. iBIO - Illinois Biotechnology Industry Organization · Capital Pulse ... 健友股份(603707)6月27日晚间公告，公司全资子公司香港健友（被许可方代表）及香港健友控股子公司Meitheal（被许可方）拟与Xentria签署许可协议，Xentria授予被许可方 ... Tom is the founding CEO of Meitheal since its inception in 2017. In addition, Tom is also the founding President of Xentria, Inc.